<?xml version="1.0"?>
<PC-AssayDescription
    xmlns="http://www.ncbi.nlm.nih.gov"
    xmlns:xs="http://www.w3.org/2001/XMLSchema-instance"
    xs:schemaLocation="http://www.ncbi.nlm.nih.gov ftp://ftp.ncbi.nlm.nih.gov/pubchem/specifications/pubchem.xsd"
>
  <PC-AssayDescription_aid>
    <PC-ID>
      <PC-ID_id>1170983</PC-ID_id>
      <PC-ID_version>2</PC-ID_version>
    </PC-ID>
  </PC-AssayDescription_aid>
  <PC-AssayDescription_aid-source>
    <PC-Source>
      <PC-Source_db>
        <PC-DBTracking>
          <PC-DBTracking_name>ChEMBL</PC-DBTracking_name>
          <PC-DBTracking_source-id>
            <Object-id>
              <Object-id_str>1442607</Object-id_str>
            </Object-id>
          </PC-DBTracking_source-id>
        </PC-DBTracking>
      </PC-Source_db>
    </PC-Source>
  </PC-AssayDescription_aid-source>
  <PC-AssayDescription_name>Inhibition of p38alpha (unknown origin) after 1 hr by homogeneous time-resolved fluorescence assay</PC-AssayDescription_name>
  <PC-AssayDescription_description>
    <PC-AssayDescription_description_E>Title: Design and synthesis of highly potent and isoform selective JNK3 inhibitors: SAR studies on aminopyrazole derivatives.</PC-AssayDescription_description_E>
    <PC-AssayDescription_description_E></PC-AssayDescription_description_E>
    <PC-AssayDescription_description_E>Abstract: The c-jun N-terminal kinase 3 (JNK3) is expressed primarily in the brain. Numerous reports have shown that inhibition of JNK3 is a promising strategy for treatment of neurodegeneration. The optimization of aminopyrazole-based JNK3 inhibitors with improved potency, isoform selectivity, and pharmacological properties by structure-activity relationship (SAR) studies utilizing biochemical and cell-based assays, and structure-based drug design is reported. These inhibitors had high selectivity over JNK1 and p38A inverted question mark, minimal cytotoxicity, potent inhibition of 6-OHDA-induced mitochondrial membrane potential dissipation and ROS generation, and good drug metabolism and pharmacokinetic (DMPK) properties for iv dosing. 26n was profiled against 464 kinases and was found to be highly selective hitting only seven kinases with &gt;80% inhibition at 10 A inverted question markM. Moreover, 26n showed good solubility, good brain penetration, and good DMPK properties. Finally, the crystal structure of 26k in complex with JNK3 was solved at 1.8 A? to explore the binding mode of aminopyrazole based JNK3 inhibitors.</PC-AssayDescription_description_E>
  </PC-AssayDescription_description>
  <PC-AssayDescription_comment>
    <PC-AssayDescription_comment_E>Compounds with activity &lt;= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E></PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Journal: J. Med. Chem.</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Year: 2014</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Volume: 57</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Issue: 23</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>First Page: 10013</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Last Page: 10030</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>DOI: 10.1021/jm501256y</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E></PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Target ChEMBL ID: CHEMBL260</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>ChEMBL Target Name: MAP kinase p38 alpha</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>ChEMBL Target Type: SINGLE PROTEIN - Target is a single protein chain</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Relationship Type: D - Direct protein target assigned</PC-AssayDescription_comment_E>
    <PC-AssayDescription_comment_E>Confidence: Direct single protein target assigned</PC-AssayDescription_comment_E>
  </PC-AssayDescription_comment>
  <PC-AssayDescription_xref>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_taxonomy>9606</PC-XRefData_taxonomy>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
      <PC-AnnotatedXRef_comment>Homo sapiens</PC-AnnotatedXRef_comment>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_pmid>25393557</PC-XRefData_pmid>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
      <PC-AnnotatedXRef_type value="pcit">1</PC-AnnotatedXRef_type>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_dburl>http://www.ebi.ac.uk/chembldb/</PC-XRefData_dburl>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_asurl>http://www.ebi.ac.uk/chembldb/index.php/assay/inspect/1442607</PC-XRefData_asurl>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
    </PC-AnnotatedXRef>
    <PC-AnnotatedXRef>
      <PC-AnnotatedXRef_xref>
        <PC-XRefData>
          <PC-XRefData_protein-gi>2499600</PC-XRefData_protein-gi>
        </PC-XRefData>
      </PC-AnnotatedXRef_xref>
    </PC-AnnotatedXRef>
  </PC-AssayDescription_xref>
  <PC-AssayDescription_results>
    <PC-ResultType>
      <PC-ResultType_tid>1</PC-ResultType_tid>
      <PC-ResultType_name>PubChem Standard Value</PC-ResultType_name>
      <PC-ResultType_description>
        <PC-ResultType_description_E>PubChem standardized value transformed from &apos;Standard Value&apos;. The unit is always micromolar</PC-ResultType_description_E>
      </PC-ResultType_description>
      <PC-ResultType_type value="float">1</PC-ResultType_type>
      <PC-ResultType_unit value="um">5</PC-ResultType_unit>
      <PC-ResultType_ac value="true"/>
    </PC-ResultType>
    <PC-ResultType>
      <PC-ResultType_tid>2</PC-ResultType_tid>
      <PC-ResultType_name>Standard Type</PC-ResultType_name>
      <PC-ResultType_description>
        <PC-ResultType_description_E>Standardized activity type (e.g. IC50 rather than Ic-50/Ic50/ic50/ic-50)</PC-ResultType_description_E>
      </PC-ResultType_description>
      <PC-ResultType_type value="string">4</PC-ResultType_type>
    </PC-ResultType>
    <PC-ResultType>
      <PC-ResultType_tid>3</PC-ResultType_tid>
      <PC-ResultType_name>Standard Relation</PC-ResultType_name>
      <PC-ResultType_description>
        <PC-ResultType_description_E>Qualifier (e.g. &gt;, &lt;, =) for &apos;Standard Value&apos;</PC-ResultType_description_E>
      </PC-ResultType_description>
      <PC-ResultType_type value="string">4</PC-ResultType_type>
    </PC-ResultType>
    <PC-ResultType>
      <PC-ResultType_tid>4</PC-ResultType_tid>
      <PC-ResultType_name>Standard Value</PC-ResultType_name>
      <PC-ResultType_description>
        <PC-ResultType_description_E>Standardized activity value transformed to common units: e.g. mM concentrations converted to nM</PC-ResultType_description_E>
      </PC-ResultType_description>
      <PC-ResultType_type value="float">1</PC-ResultType_type>
    </PC-ResultType>
    <PC-ResultType>
      <PC-ResultType_tid>5</PC-ResultType_tid>
      <PC-ResultType_name>Standard Units</PC-ResultType_name>
      <PC-ResultType_description>
        <PC-ResultType_description_E>Selected units for &apos;Standard Type&apos;: e.g. concentrations are in nM</PC-ResultType_description_E>
      </PC-ResultType_description>
      <PC-ResultType_type value="string">4</PC-ResultType_type>
    </PC-ResultType>
  </PC-AssayDescription_results>
  <PC-AssayDescription_revision>1</PC-AssayDescription_revision>
  <PC-AssayDescription_target>
    <PC-AssayTargetInfo>
      <PC-AssayTargetInfo_name>Mitogen-activated protein kinase 14</PC-AssayTargetInfo_name>
      <PC-AssayTargetInfo_mol-id>2499600</PC-AssayTargetInfo_mol-id>
      <PC-AssayTargetInfo_molecule-type value="protein">1</PC-AssayTargetInfo_molecule-type>
      <PC-AssayTargetInfo_organism>
        <BioSource>
          <BioSource_org>
            <Org-ref>
              <Org-ref_db>
                <Dbtag>
                  <Dbtag_db>taxon</Dbtag_db>
                  <Dbtag_tag>
                    <Object-id>
                      <Object-id_id>9606</Object-id_id>
                    </Object-id>
                  </Dbtag_tag>
                </Dbtag>
              </Org-ref_db>
              <Org-ref_orgname>
                <OrgName>
                  <OrgName_name>
                    <OrgName_name_binomial>
                      <BinomialOrgName>
                        <BinomialOrgName_genus>Homo sapiens</BinomialOrgName_genus>
                      </BinomialOrgName>
                    </OrgName_name_binomial>
                  </OrgName_name>
                </OrgName>
              </Org-ref_orgname>
            </Org-ref>
          </BioSource_org>
        </BioSource>
      </PC-AssayTargetInfo_organism>
      <PC-AssayTargetInfo_descr>MAP kinase p38 alpha</PC-AssayTargetInfo_descr>
      <PC-AssayTargetInfo_comment>
        <PC-AssayTargetInfo_comment_E>Protein Accession: Q16539</PC-AssayTargetInfo_comment_E>
      </PC-AssayTargetInfo_comment>
    </PC-AssayTargetInfo>
  </PC-AssayDescription_target>
  <PC-AssayDescription_activity-outcome-method value="confirmatory">2</PC-AssayDescription_activity-outcome-method>
  <PC-AssayDescription_project-category value="literature-extracted">7</PC-AssayDescription_project-category>
  <PC-AssayDescription_assay-group>
    <PC-AssayDescription_assay-group_E>PMID: 25393557</PC-AssayDescription_assay-group_E>
  </PC-AssayDescription_assay-group>
</PC-AssayDescription>
